Journal Report

WORLD ALLERGY ORGANIZATION JOURNAL

Download PDF
Journal Information
Journal Title
WORLD ALLERGY ORGANIZATION JOURNAL
Publisher
ELSEVIER
ISSN
1939-4551
E-ISSN
1939-4551
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Clinical utility of Oriton IgE CHEMIPHAR™ for predicting skin prick test positivity in patients with allergic airway diseases
Erika Naito, Tomoyuki Soma, Kazuyuki Nakagome et al.
2026-11 Vol. 19 Issue 11 Pages 101479
DOI: 10.1016/j.waojou.2026.101479
Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma
Wenhua Ming, Yang Zhou, Tingting Liu et al.
2026-11 Vol. 19 Issue 11 Pages 101478
DOI: 10.1016/j.waojou.2026.101478
Biologic therapies for atopic diseases during pregnancy: A World Allergy Organization survey
Sergio E. Chiarella, Isabella Novoa-Caicedo, Sarah M. Jenkins et al.
2026-11 Vol. 19 Issue 11 Pages 101485
DOI: 10.1016/j.waojou.2026.101485
Landscape of hereditary angioedema in China: A multicenter cross-sectional questionnaire survey
Yingyang Xu, Wei Chen, Timothy Craig et al.
2026-11 Vol. 19 Issue 11 Pages 101483
DOI: 10.1016/j.waojou.2026.101483
Allergic rhinitis as a potentially modifiable contributor to small airway dysfunction and incomplete clinical remission in severe asthma
Huan Wu, Qin Ouyang
2026-11 Vol. 19 Issue 11 Pages 101484
DOI: 10.1016/j.waojou.2026.101484
Olive allergens under the microscope: Ole e 7 and Ole e 9 sensitization does not increase symptom severity or adverse reactions to subcutaneous allergen immunotherapy
Manuel Alcántara Villar, Alicia López Guerrero, Miriam Bermúdez Bejarano et al.
2026-11 Vol. 19 Issue 11 Pages 101482
DOI: 10.1016/j.waojou.2026.101482
Executive Summary of the 2025 World Allergy Organization Guidelines for Hereditary Angioedema
Pedro Giavina-Bianchi, Daniel O. Vazquez, Dario Josviack et al.
2026-11 Vol. 19 Issue 11 Pages 101481
DOI: 10.1016/j.waojou.2026.101481
Long-term prophylactic treatment and related real-world outcomes of patients with hereditary angioedema in Germany: A retrospective analysis of German claims and medical chart data
Jens Greve, Nils Picker, Fabian Jülich et al.
2026-10 Vol. 19 Issue 10 Pages 101469
DOI: 10.1016/j.waojou.2026.101469
Oral 5-HT3 receptor antagonist for at-home management of acute FPIES episodes in adults: A real-world observational study
Sho Watanabe, Ayako Sato, Hiroto Seki et al.
2026-10 Vol. 19 Issue 10 Pages 101473
DOI: 10.1016/j.waojou.2026.101473
Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies
Aleena Banerji, Jonathan A. Bernstein, Laurence Bouillet et al.
2026-10 Vol. 19 Issue 10 Pages 101474
DOI: 10.1016/j.waojou.2026.101474
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 00:04